Sponsor or institution
Clinical trials and research at Neurexis Therapeutics, INC.
As of November 12, 2026, Find a Trial lists 5 NIH-funded research projects at this institution, with $3.8 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5NIH research projects
NIH-funded research (5)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Neuroprotective peptide therapy for global brain injury after cardiac arrest
A promising peptide drug (tatCN19o) is being prepared for human testing to protect the brain after cardiac arrest and global brain ischemia.
-
Neuroprotective peptide to help people with Alzheimer’s disease
A patient-focused study tests whether a peptide that protects brain cells during injury can also help improve memory and thinking in people impacted by Alzheimer’s disease.
-
A potential brain-protecting drug for people with brain injury after cardiac arrest
A new drug is being developed to protect the brain in people who suffer severe lack of oxygen to the brain after cardiac arrest.
-
Testing a new treatment to protect the brain after a stroke
This study is testing a new treatment called tatCN19o to see if it can help protect the brain during and after a stroke, using small doses in rodent models to find out how well it works compared to current treatments.
-
Developing a new drug to protect the brain after cardiac arrest
This study is testing a new drug designed to help protect the brain after a cardiac arrest, and it's for people who want to see better recovery outcomes after such an event.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.